Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign Language
Launched by POITIERS UNIVERSITY HOSPITAL · Mar 24, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Person aged ≥ 18 yo
- • with severe or profound deafness (hearing loss ≥ 70 decibels)
- • whose main language is French Sign Language
- • able to consent in writing after a clear explanation of the procedure
- • affiliated to the French Healthcare system (Sécurité Sociale) through self or another person
- Non-inclusion criteria:
- • person with a medical history in neurology (stroke, traumatic brain injury, dementia) or psychiatry bipolar syndrom or schizophrenia that would not be medicated, severe depression)
- • persons with medical developmental backgroung (e.g genetic syndrome)
- • person with cancer history needing chemotherapy
- • person with a diagnosed and untreated sleeping trouble
- • person drinking \> 10 glasses of alcohol per week or using drugs on a daily basis
- • person with visual issues
- • person under 18yo or unable to take decisions for self
- Exclusion Criteria:
- • A score ≤ 20/28 or 17/28 at the MMS-LS test, depending on the schooling of the participant (20/28 for participants with a degree, 17/28 for participants without a degree)
Trial Officials
Pierre-Alexandre BERARD, Speech-Language Pathologist
Principal Investigator
Poitiers University Hospital
About Poitiers University Hospital
Poitiers University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to explore new therapeutic interventions and improve patient outcomes. With a commitment to ethical standards and patient safety, Poitiers University Hospital collaborates with healthcare professionals, researchers, and institutions to facilitate groundbreaking studies that contribute to medical knowledge and enhance treatment protocols across various specialties.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
